Revisiting human primary immunodeficiencies

Journal of Internal Medicine

Volumn 264, Issue 2, 2008, Pages 115-127

  Casanova, Jean Laurent ^a,b,c   Fieschi, Claire ^d   Zhang, Shen Ying ^b,c,e   Abel, Laurent ^b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b IMAGINE INSTITUTE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Human genetics; Immunity; Infectious diseases; Primary immunodeficiencies

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; COMPLEMENT MEMBRANE ATTACK COMPLEX; FAS ANTIGEN; GAMMA INTERFERON RECEPTOR 1; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 12P40; PROPERDIN; STAT1 PROTEIN;

ALLELE; BACTERIAL INFECTION; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE MUTATION; GENE THERAPY; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; LEPROSY; MIXED INFECTION; NEISSERIA; NOROVIRUS; PHENOTYPE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REVIEW; STEM CELL TRANSPLANTATION; TUBERCULOSIS; VIRUS INFECTION; VIRUS REPLICATION;

ADULT; ANTIGENS, CD95; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; ENCEPHALITIS, HERPES SIMPLEX; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LEPROSY; MALE; PHENOTYPE; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN-12;

EID: 47049098425     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01971.x     Document Type: Review

References (108)

1. Ochs H, Smith CIE, Puck J. Primary Immunodeficiencies: A Molecular and Genetic Approach. New York : Oxford University Press, 2007.
2. Stiehm ER, Ochs HD, Winkelstein JA. Immunologic Disorders in Infants and Children. Philadelphia, PA : Elsevier Saunders, 2004.
3. Notarangelo L, Casanova JL, Conley ME et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 2006 117 : 883 96.
4. Notarangelo L, Casanova JL, Fischer A et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2004 114 : 677 87.
5. Casanova JL, Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med 2005 202 : 197 201.
6. Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science 2007 317 : 617 9.
7. Casanova JL, Fieschi C, Bustamante J et al. From idiopathic infectious diseases to novel primary immunodeficiencies. J Allergy Clin Immunol 2005 116 : 426 30.
8. Geha RS, Notarangelo LD, Casanova JL et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007 120 : 776 94.
9. Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol 2007 7 : 851 61.
10. Fischer A. Human primary immunodeficiency diseases. Immunity 2007 27 : 835 45.
11. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976 295 : 302 4.
12. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 1975 189 : 561 3.
13. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995 10 : 224 8.
14. Arenzana-Seisdedos F, Parmentier M. Genetics of resistance to HIV infection: role of co-receptors and co-receptor ligands. Semin Immunol 2006 18 : 387 403.
15. Brown KE, Hibbs JR, Gallinella G et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994 330 : 1192 6.
16. Lindesmith L, Moe C, Marionneau S et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003 9 : 548 53.
17. Kindberg E, Hejdeman B, Bratt G et al. A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection. AIDS 2006 20 : 685 9.
18. Le Pendu J, Ruvoen-Clouet N, Kindberg E, Svensson L. Mendelian resistance to human norovirus infections. Semin Immunol 2006 18 : 375 86.
19. Kindberg E, Akerlind B, Johnsen C et al. Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J Clin Microbiol 2007 45 : 2720 2.
20. Larsson MM, Rydell GE, Grahn A et al. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis 2006 194 : 1422 7.
21. Thorven M, Grahn A, Hedlund KO et al. A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol 2005 79 : 15351 5.
22. Lindell AT, Grillner L, Svensson L, Wirgart BZ. Molecular epidemiology of norovirus infections in Stockholm, Sweden, during the years 2000 to 2003: association of the GGIIb genetic cluster with infection in children. J Clin Microbiol 2005 43 : 1086 92.
23. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoen-Clouet N. Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis 2005 192 : 1071 7.
24. Marionneau S, Ruvoen N, Le Moullac-Vaidye B et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002 122 : 1967 77.
25. Finsterer J. Hematological manifestations of primary mitochondrial disorders. Acta Haematol 2007 118 : 88 98.
26. Lawrence T, Puel A, Reichenbach J et al. Autosomal-dominant primary immunodeficiencies. Curr Opin Hematol 2005 12 : 22 30.
27. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007 370 : 1443 52.
28. Casrouge A, Zhang SY, Eidenschenk C et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006 314 : 308 12.
29. Jouanguy E, Zhang SY, Chapgier A et al. Human primary immunodeficiencies of type I interferons. Biochimie 2007 89 : 878 83.
30. Sancho-Shimizu V, Zhang SY, Abel L et al. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr Opin Allergy Clin Immunol 2007 7 : 495 505.
31. Zhang SY, Jouanguy E, Sancho-Shimizu V et al. The roles of human Toll like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 2007 220 : 225 36.
32. Zhang SY, Jouanguy E, Ugolini S et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007 317 : 1522 7.
33. Castigli E, S. Geha R Molecular basis of common variable immunoficiency. J Allergy Clin Immunol 2006 117 : 740 6.
34. Salzer U, Grimbacher B. Common variable immunodeficiency: the power of co-stimulation. Semin Immunol 2006 18 : 337 46.
35. Schaffer AA, Salzer U, Hammarstrom L, Grimbacher B. Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007 17 : 201 12.
36. Grimbacher B, Hutloff A, Schlesier M et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003 4 : 261 8.
37. Salzer U, Chapel HM, Webster AD et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005 37 : 820 8.
38. Castigli E, Wilson SA, Garibyan L et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005 37 : 829 34.
39. van Zelm MC, Reisli I, van der Burg M et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006 354 : 1901 12.
40. Pan-Hammarstrom Q, Salzer U, Du L et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007 39 : 429 30.
41. Laffort C, Le Deist F, Favre M et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 2004 363 : 2051 4.
42. Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003 302 : 415 9.
43. Altare F, Durandy A, Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998 280 : 1432 5.
44. Altare F, Lammas D, Revy P et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 1998 102 : 2035 40.
45. de Jong R, Altare F, Haagen IA et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998 280 : 1435 8.
46. Picard C, Fieschi C, Altare F et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002 70 : 336 48.
47. Fieschi C, Dupuis S, Catherinot E et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003 197 : 527 35.
48. Bidere N, Su HC, Lenardo MJ. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 2006 24 : 321 52.
49. Ku CL, von Bernuth H, Picard C et al. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity. J Exp Med 2007 204 : 2407 22.
50. Picard C, Puel A, Bonnet M et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003 299 : 2076 9.
51. Ku CL, Yang K, Bustamante J et al. Inherited disorders of human Toll-like receptor signalling: immunological implications. Immunol Rev 2005 203 : 10 20.
52. Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol 2004 16 : 34 41.
53. Yang K, Puel A, Zhang S et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005 23 : 465 78.
54. Harbord MW, Marks DJ, Forbes A, Bloom SL, Day RM, Segal AW. Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Aliment Pharmacol Ther 2006 24 : 651 60.
55. Marks DJ, Harbord MW, MacAllister R et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006 367 : 668 78.
56. Marks DJ, Mitchison NA, Segal AW, Sieper J. Can unresolved infection precipitate autoimmune disease? Curr Top Microbiol Immunol 2006 305 : 105 25.
57. Marks DJ, Radulovic M, McCartney S, Bloom S, Segal AW. Modified skin window technique for the extended characterisation of acute inflammation in humans. Inflamm Res 2007 56 : 168 74.
58. Marks D, Segal A. Innate immunity in inflammatory bowel disease: a disease hypothesis. J Pathol 2007 214 : 260 6.
59. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 314 : 1461 3.
60. Hugot JP. CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci 2006 1072 : 9 18.
61. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006 3 : 390 407.
62. Mathew S, Overturf GD. Complement and properidin deficiencies in meningococcal disease. Pediatr Infect Dis J 2006 25 : 255 6.
63. Picard C, Casanova JL, Abel L. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr Opin Immunol 2006 18 : 383 90.
64. Picard C, Puel A, Ku CL, Casanova JL. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 2003 3 : 451 9.
65. Rigaud S, Fondaneche MC, Lambert N et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006 444 : 110 4.
66. Fieschi C, Casanova JL. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur J Immunol 2003 33 : 1461 4.
67. Fieschi C, Bosticardo M, De Beaucoudrey L et al. A novel form of complete IL-12/IL-23 receptor {beta}1 deficiency with cell surface-expressed nonfunctional receptors. Blood 2004 104 : 2095 101.
68. Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 2005 202 : 1617 21.
69. Altare F, Ensser A, Breiman A et al. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001 184 : 231 6.
70. Caragol I, Raspall M, Fieschi C et al. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis 2003 37 : 302 6.
71. Özbek N, Fieschi C, Yilmaz BT et al. Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis. Clin Infect Dis 2005 40 : e55 8.
72. Doffinger R, Smahi A, Bessia C et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001 27 : 277 85.
73. Orth G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 2006 18 : 362 74.
74. Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999 112 : 259 63.
75. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002 32 : 579 81.
76. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008 205 : 35 42.
77. Antunes MB, Cohen NA. Mucociliary clearance-a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol 2007 7 : 5 10.
78. Chapgier A, Boisson-Dupuis S, Jouanguy E et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2006 2 : e131.
79. Chapgier A, Wynn RF, Jouanguy E et al. Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 2006 176 : 5078 83.
80. Dupuis S, Dargemont C, Fieschi C et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001 293 : 300 3.
81. Dupuis S, Doffinger R, Picard C et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000 178 : 129 37.
82. Dupuis S, Jouanguy E, Al-Hajjar S et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003 33 : 388 91.
83. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002 20 : 581 620.
84. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000 11 : 321 33.
85. Filipe-Santos O, Bustamante J, Chapgier A et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006 18 : 347 61.
86. Dorman SE, Picard C, Lammas D et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004 364 : 2113 21.
87. Jouanguy E, Lamhamedi-Cherradi S, Lammas D et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nature Genet 1999 21 : 370 8.
88. Okada S, Ishikawa N, Shirao K et al. The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-gamma receptor 1 and has a dominant-negative effect on interferon-gamma signal transduction. J Med Genet 2007 44 : 485 91.
89. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996 335 : 1956 61.
90. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996 335 : 1941 9.
91. Glosli H, Stray-Pedersen A, Brun AC et al. Infections due to various atypical mycobacteria in a norwegian multiplex family with dominant interferon-gamma receptor deficiency. Clin Infect Dis 2008 46 : e23 7.
92. Noordzij JG, Hartwig NG, Verreck FA et al. Two patients with complete defects in interferon gamma receptor-dependent signaling. J Clin Immunol 2007 27 : 490 6.
93. Alcais A, Alter A, Antoni G et al. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 2007 39 : 517 22.
94. Alcais A, Mira M, Casanova JL, Schurr E, Abel L. Genetic dissection of immunity in leprosy. Curr Opin Immunol 2005 17 : 44 8.
95. Mira MT, Alcais A, Nguyen VT et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004 427 : 636 40.
96. Mira MT, Alcais A, Van Thuc N et al. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 2003 33 : 412 5.
97. Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 1996 13 : 290 5.
98. Uzel G, Tng E, Rosenzweig SD et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood 2008 111 : 209 18.
99. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J Med Genet 2003 40 : 721 8.
100. Holzelova E, Vonarbourg C, Stolzenberg MC et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004 351 : 1409 18.
101. Doffinger R, Helbert MR, Barcenas-Morales G et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 2004 38 : e10 4.
102. Kampmann B, Hemingway C, Stephens A et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest 2005 115 : 2480 8.
103. Hoflich C, Sabat R, Rosseau S et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004 103 : 673 5.
104. Puel A, Picard C, Lorrot M et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol 2008 180 : 647 54.
105. Alcais A, Abel L, Casanova JL Human genetics of infectious diseases. In : Vogel F, Motulsky AG, Antonarakis SE, Speicher M, eds. Human Genetics: Principles and Approaches. Springer-Verlag, 2008 (in press).
106. Casanova JL, Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 2004 4 : 55 66.
107. Casanova JL, Abel L. Human genetics of infectious diseases: a unified theory. EMBO J 2007 26 : 915 22.
108. Quintana-Murci L, Alcais A, Abel L, Casanova JL. Immunology in natura: clinical, epidemiological, and evolutionary genetics of infectious diseases. Nat Immunol 2007 8 : 1165 71.